Clinical Trial Update: Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies

View source ↗

Summary

This NIH clinical trial studied generating anti-HCV antibodies from bone marrow to map the repertoire of immune responses to Hepatitis C quasispecies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Hepatitis C | Status: COMPLETED